14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KURA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for Kura Oncology stock after gaining 3.76%
(Updated on Apr 22, 2024)

Sell candidate since Apr 16, 2024 Loss -2.15% PDF

The Kura Oncology stock price gained 3.76% on the last trading day (Monday, 22nd Apr 2024), rising from $17.53 to $18.19. During the last trading day the stock fluctuated 7.03% from a day low at $17.92 to a day high of $19.18. The price has fallen in 7 of the last 10 days and is down by -10.92% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 656 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $36.12 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Kura Oncology stock with a 90% probability to be traded between $13.88 and $23.97 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KURA Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kura Oncology stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $18.35 and $20.79. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -22.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Kura Oncology stock

Kura Oncology finds support from accumulated volume at $17.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.26 between high and low, or 7.03%. For the last week, the stock has had daily average volatility of 5.01%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KURA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Kura Oncology to open at $18.43, and during the day (based on 14 day Average True Range), to move between $17.13 and $19.25, which gives a possible trading interval of +/-$1.06 (+/-5.81%) up or down from last closing price. If Kura Oncology takes out the full calculated possible swing range there will be an estimated 11.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $17.98 (1.15%) than the resistance at $18.73 (2.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kura Oncology stock A Buy?

Kura Oncology holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.198 Sell Candidate Unchanged

Predicted Opening Price for Kura Oncology of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$18.43 ( 1.32%) $18.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KURA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 19.69 8.25 %
R2 19.21 5.60 %
R1 18.91 3.97 %
Current price: 18.19
Support S1 17.95 -1.33 %
S2 17.65 -2.96 %
S3 17.17 -5.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 20.85 14.62 %
R2 19.61 7.81 %
R1 18.73 2.97 %
Current price 18.19
Support S1 17.98 -1.15%
S2 17.68 -2.80%
S3 17.53 -3.63%

FAQ

What is the symbol for Kura Oncology Stock and on which exchange is it traded?
The symbol for Kura Oncology is KURA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kura Oncology Stock?
Kura Oncology holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Kura Oncology Stock?
Kura Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kura Oncology Stock.

What's the current price of Kura Oncology Stock?
As of the end of day on the Apr 22, 2024, the price of an Kura Oncology (KURA) share was $18.19.

What is the 52-week high and low for Kura Oncology Stock?
The 52-week high for Kura Oncology Stock is $24.16 and the 52-week low is $7.41.

What is the market capitalization of Kura Oncology Stock?
As of the Apr 22, 2024, the market capitalization of Kura Oncology is 1.385B.

When is the next earnings date for Kura Oncology?
The upcoming earnings date for Kura Oncology is May 08, 2024.
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT